Belgian soft mist inhaler company Softhale has announced the appointment of Nevan Charles Elam to its board of directors. Currently Chairman and CEO of Rezolute, Elam was formerly Senior VP and Head of the Pulmonary Business Unit at Nektar Therapeutics. He has served on the boards of Nektar spin-out Pearl Therapeutics and Aerogen, and currently serves on the board of … [Read more...] about Nevan Charles Elam joins board of Softhale
People
David Harris joins Cambridge Design Partnership
Cambridge Design Partnership (CDP) has announced the appointment of OINDP device designer David Harris to head up the company's respiratory drug delivery development business. According to CDP, the company is entering "a new phase of growth in the sector." Harris was previously Head of Respiratory Drug Delivery at PA Consulting and at Team Consulting and also … [Read more...] about David Harris joins Cambridge Design Partnership
Phillips-Medisize CEO Matt Jennings appointed to Dance Biopharm board of directors
Dance Biopharm has announced the appointment of Phillips-Medisize President and CEO Matt Jennings to its board of directors. Phillips-Medisize is developing a connected version of Dance’s insulin soft mist inhaler device. Jennings joined Phillips-Medisize as Chairman, CEO and President in 2011; his prior experience includes 5 years as President of Teleflex and 2 … [Read more...] about Phillips-Medisize CEO Matt Jennings appointed to Dance Biopharm board of directors
Experic hires OINDP specialist, announces plans for new facility and DPI services
US-based pharmaceutical supply services firm Experic is expanding its focus with the appointment of DPI expert Justin Lacombe as Director of Pharmaceutical Development and Manufacturing Services and the announcement that the company has leased a new facility that will offer development and manufacturing services for a variety of dosage forms, including dry powder … [Read more...] about Experic hires OINDP specialist, announces plans for new facility and DPI services
Dance Biopharm appoints Anne Whitaker as CEO
Inhaled insulin developer Dance Biopharm has announced the appointment of former Novoclem Pharmaceuticals President and CEO Anne Whitaker as a Director and CEO as of October 1st, 2018. In addition to founding and heading up inhaled drug developer Novoclem, Whitaker has also held executive positions at Bausch Health, Synta Pharmaceuticals, Sanofi, and GSK. Earlier … [Read more...] about Dance Biopharm appoints Anne Whitaker as CEO
Roivant launches new company to develop cromolyn inhalation solution
Roivant, which recently acquired Patara Pharma's cromolyn sodium inhalation solution for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF), has launched a company called Respivant to develop the drug. The new company will be led by former Patara CEO Bill Gerhart. Gerhart has extensive experience in inhaled drug development; having … [Read more...] about Roivant launches new company to develop cromolyn inhalation solution
Iconovo appoints Mikael Ekström as VP of Development
Device developer Iconovo AB has announced the appointment of Mikael Ekström as its new VP, Development effective September 1, 2018. Ekström held various positions at AstraZeneca over a period of almost 30 years, most recently as Senior Director Inhalation Product Development. Iconovo said that Ekström's hire "is an important reinforcement of Iconovo's organization … [Read more...] about Iconovo appoints Mikael Ekström as VP of Development
Rick Batycky to leave Acorda ahead of FDA decision on Inbrija
Acorda Therapeutics has announced that Chief Technology Officer Rick Batycky is leaving the company as of August 20, 2018 to head up a new private biotech firm. Batycky co-founded Civitas Therapeutics, which was acquired by Acorda in 2014, along with its CVT-301 levodopa DPI, (now known as Inbrija) and the ARCUS dry powder inhalation platform. The company filed … [Read more...] about Rick Batycky to leave Acorda ahead of FDA decision on Inbrija
Proveris hires John Masciola as VP of Product Development
Proveris Scientific Corporation has announced the appointment of John Masciola as VP of Product Development. Masciola was most recently Engineering Manager at Parker Precision Fluidics, and his experience in the life sciences industry includes positions as Director of Instrument Engineering and Director of R&D at Perkin Elmer and VP of Engineering at Zymark/Caliper … [Read more...] about Proveris hires John Masciola as VP of Product Development
Cohero Health announces new management hires
Cohero Health has announced 5 new hires "to scale for growth and drive commercial sales of its BreatheSmart platform." In 2016, Cohero and H&T Presspart announced that they had partnered on development of an electronic inhaler called the eMDI. The new hires are: Amber Thompson, Chief Client Officer; Sergio Carbone, Chief Information and Technology Officer; Yury … [Read more...] about Cohero Health announces new management hires